Search Results - "Schermer, Maartje H. N."

Refine Results
  1. 1
  2. 2

    Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial by Noordraven, Ernst L, Schermer, Maartje H N, Blanken, Peter, Mulder, Cornelis L, Wierdsma, André I

    Published in BMC psychiatry (29-08-2017)
    “…A randomized controlled trial 'Money for Medication'(M4M) was conducted in which patients were offered financial incentives for taking antipsychotic depot…”
    Get full text
    Journal Article
  3. 3

    Good health checks according to the general public; expectations and criteria: a focus group study by Stol, Yrrah H, Asscher, Eva C A, Schermer, Maartje H N

    Published in BMC medical ethics (22-06-2018)
    “…Health checks or health screenings identify (risk factors for) disease in people without a specific medical indication. So far, the perspective of (potential)…”
    Get full text
    Journal Article
  4. 4

    Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues by Bunnik, Eline M, Schermer, Maartje H N, Janssens, A Cecile J W

    Published in BMC medical ethics (14-06-2011)
    “…As genetics technology proceeds, practices of genetic testing have become more heterogeneous: many different types of tests are finding their way to the public…”
    Get full text
    Journal Article
  5. 5

    What is a good health check? An interview study of health check providers' views and practices by Stol, Yrrah H, Asscher, Eva C A, Schermer, Maartje H N

    Published in BMC medical ethics (02-10-2017)
    “…Health checks identify (risk factors for) disease in people without symptoms. They may be offered by the government through population screenings and by other…”
    Get full text
    Journal Article
  6. 6

    Personal utility in genomic testing: is there such a thing? by Bunnik, Eline M, Janssens, A Cecile J W, Schermer, Maartje H N

    Published in Journal of medical ethics (01-04-2015)
    “…In ethical and regulatory discussions on new applications of genomic testing technologies, the notion of ‘personal utility’ has been mentioned repeatedly. It…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Public Attitudes Towards Moral Enhancement. Evidence that Means Matter Morally by Specker, Jona, Schermer, Maartje H. N., Reiner, Peter B.

    Published in Neuroethics (01-10-2017)
    “…To gain insight into the reasons that the public may have for endorsing or eschewing pharmacological moral enhancement for themselves or for others, we used…”
    Get full text
    Journal Article
  9. 9
  10. 10

    On the reconceptualization of Alzheimer’s disease by Schermer, Maartje H. N., Richard, Edo

    Published in Bioethics (01-01-2019)
    “…In the hope of future treatments to prevent or slow down the disease, there is a strong movement towards an ever‐earlier detection of Alzheimer’s disease (AD)…”
    Get full text
    Journal Article
  11. 11

    Informed Consent in Direct-to-Consumer Personal Genome Testing: The Outline of A Model between Specific and Generic Consent by Bunnik, Eline M., Janssens, A. Cecile J.W., Schermer, Maartje H.N.

    Published in Bioethics (01-09-2014)
    “…Broad genome‐wide testing is increasingly finding its way to the public through the online direct‐to‐consumer marketing of so‐called personal genome tests…”
    Get full text
    Journal Article
  12. 12

    Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease by Schermer, Maartje H N

    Published in The Journal of medicine and philosophy (20-06-2023)
    “…Abstract Alzheimer’s Disease (AD) provides an excellent case study to investigate emerging conceptions of health, disease, pre-disease, and risk. Two…”
    Get full text
    Journal Article
  13. 13

    The Ethics of Cancer Screening Based on Race and Ethnicity by Mülder, Duco T, O'Mahony, James F, Doubeni, Chyke A, Lansdorp-Vogelaar, Iris, Schermer, Maartje H N

    Published in Annals of internal medicine (01-09-2024)
    “…Racial and ethnic disparities in incidence and mortality are well documented for many types of cancer. As a result, there is understandable policy and clinical…”
    Get full text
    Journal Article
  14. 14

    The Framing of “Alzheimer’s Disease”: Differences Between Scientific and Lay Literature and Their Ethical Implications by Smedinga, Marthe, Bunnik, Eline M, Richard, Edo, Schermer, Maartje H N

    Published in The Gerontologist (01-08-2021)
    “…Abstract Background and Objectives The meaning of Alzheimer’s disease (AD) is changing in research. It now refers to a pathophysiological process, regardless…”
    Get full text
    Journal Article
  15. 15

    Naming and framing in genomic testing by Bunnik, Eline M, Schermer, Maartje H.N, Janssens, A. Cecile J.W

    Published in Trends in molecular medicine (01-02-2014)
    “…What's in a name? Terminology has the power to shape the ethical and regulatory debate surrounding commercially offered genomic testing. This article discusses…”
    Get full text
    Journal Article
  16. 16

    Towards machine learning for moral choice analysis in health economics: A literature review and research agenda by Smeele, Nicholas V.R., Chorus, Caspar G., Schermer, Maartje H.N., de Bekker-Grob, Esther W.

    Published in Social science & medicine (1982) (01-06-2023)
    “…Discrete choice models (DCMs) for moral choice analysis will likely lead to erroneous model outcomes and misguided policy recommendations, as only some…”
    Get full text
    Journal Article
  17. 17

    On the personal utility of Alzheimer’s disease-related biomarker testing in the research context by Bunnik, Eline M, Richard, Edo, Milne, Richard, Schermer, Maartje H N

    Published in Journal of medical ethics (01-12-2018)
    “…Many healthy volunteers choose to take part in Alzheimer’s disease (AD) prevention studies because they want to know whether they will develop dementia—and…”
    Get full text
    Journal Article
  18. 18

    A tiered-layered-staged model for informed consent in personal genome testing by Bunnik, Eline M, Janssens, A Cecile J W, Schermer, Maartje H N

    Published in European journal of human genetics : EJHG (01-06-2013)
    “…In recent years, developments in genomics technologies have led to the rise of commercial personal genome testing (PGT): broad genome-wide testing for multiple…”
    Get full text
    Journal Article
  19. 19

    Early-Phase Clinical Trials of Bio-Artificial Organ Technology: A Systematic Review of Ethical Issues by de Jongh, Dide, Massey, Emma K., Cronin, Antonia J., Schermer, Maartje H. N., Bunnik, Eline M.

    Published in Transplant international (31-10-2022)
    “…Regenerative medicine has emerged as a novel alternative solution to organ failure which circumvents the issue of organ shortage. In preclinical research…”
    Get full text
    Journal Article
  20. 20

    Exploring health and disease concepts in healthcare practice: an empirical philosophy of medicine study by van der Linden, Rik R, Schermer, Maartje H N

    Published in BMC medical ethics (27-03-2024)
    “…In line with recent proposals for experimental philosophy and philosophy of science in practice, we propose that the philosophy of medicine could benefit from…”
    Get full text
    Journal Article